Invesco Dynamic Biotechnology & Genome ETF

Price: $64.99
Change: $0.04 (-0.0%)
Last Updated:


Issuer Invesco
Brand Invesco
Structure ETF
Expense Ratio 0.59%
ETF Home Page Home page
Inception Jun 23, 2005

Analyst Report

This ETF offers exposure to the biotech sub-sector of the U.S. health care industry, serving up access to a group of stocks that can thrive on technological breakthroughs and increased investment in medical processes. PBE is part of the suite of Dynamic ETFs from PowerShares, using quant-based screening to identify component companies that may be poised for outperformance relative to a broad-based universe. As such, the portfolio of this ETF is considerably more limited than IBB, which includes more than 100 individual names. That feature can be particularly important in the biotech space, where company-specific developments can send a single stock soaring. PBE does a nice job of spreading exposure evenly across the portfolio components, which include a balance of large caps, mid caps, and small cap stocks. IBB and FBT are other ETF options for biotech exposure; those considering this sector should take a close look at depth of exposure and weighing methodology, as these factors can have a major impact on the risk and return profiles achieved. The expense differentials are also worth noting; PBE is a bit more expensive than the iShares alternative.

ETF Database Themes

Asset Class Equity
Asset Class Size Multi-Cap
Asset Class Style Growth
Sector (General) Healthcare
Sector (Specific) Biotechnology
Region (General) North America
Region (Specific) U.S.

FactSet Classifications

Segment Equity: U.S. Biotechnology
Category Sector
Focus Health Care
Niche Biotechnology
Strategy Multi-factor
Weighting Scheme Tiered

Trading Data

Open - Volume -
Day Lo - Day Hi -
  • Open
  • Volume
  • Day Lo
  • Day Hi
  • 52 Week Lo $51.39
  • 52 Week Hi $73.06
  • AUM $257.8 M
  • Shares 4.0 M

Historical Trading Data

  • 1 Month Avg. Volume 6,908
  • 3 Month Avg. Volume 8,876

Alternative ETFs in the ETF Database Health & Biotech Equities Category

Type Symbol Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest FHLC 0.08% $3.1 B 168,085 -5.51%
Largest (AUM) XLV 0.10% $41.9 B 9 M -2.13%
Most Liquid (Volume) XBI 0.35% $7.8 B 11 M -27.65%
Top YTD Performer FTXH 0.60% $42.5 M 12,265 2.26%

Alternative ETFs in the FactSet Equity: U.S. Biotechnology Segment

Type Symbol Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest XBI 0.35% $7.8 B 11 M -27.65%
Largest (AUM) IBB 0.44% $8.9 B 2 M -12.27%
Most Liquid (Volume) XBI 0.35% $7.8 B 11 M -27.65%
Top YTD Performer BBP 0.79% $16.9 M 1,077 -1.56%

Top 15 Holdings

Concentration Analysis

This section compares how balanced and deep this ETF is relative to its peers.

Holdings Comparison

PBE ETF Database Category Average FactSet Segment Average
Number of Holdings 31 93 127
% of Assets in Top 10 51.58% 43.91% 35.85%
% of Assets in Top 15 66.39% 56.88% 47.24%
% of Assets in Top 50 100.01% 90.95% 85.67%

Size Comparison

PBE ETF Database Category Average FactSet Segment Average
Large (>12.9B) 41.11% 49.79% 34.20%
Mid (>2.7B) 28.82% 23.40% 29.86%
Small (>600M) 30.06% 19.20% 32.53%
Micro (<600M) 0.00% 4.92% 3.21%

PBE Valuation

This section compares the P/E ratio of this ETF to its peers.

P/E Ratio
ETF Database Category Average
P/E Ratio
FactSet Segment Average
P/E Ratio

PBE Dividend

This section compares the dividend yield of this ETF to its peers.

PBE ETF Database Category Average FactSet Segment Average
Dividend $ 0.03 $ 0.17 $ 0.05
Dividend Date 2020-03-23 N/A N/A
Annual Dividend Rate N/A $ 0.42 $ 0.09
Annual Dividend Yield N/A 0.36% 0.07%

PBE Price and Volume Charts

View charts featuring PBE price and volume data.

PBE Fund Flows Charts

View charts featuring ETF fund flow data.

5 Day Net Flows: 0 1 Month Net Flows: 1.26 M 3 Month Net Flows: 2.4 M 6 Month Net Flows: 11.25 M 1 Year Net Flows: 3.52 M 3 Year Net Flows: -13.35 M 5 Year Net Flows: -45.53 M 10 Year Net Flows: -73.41 M

PBE Price vs Flows AUM Influence Charts

View charts that break down the influence that fund flows and price had on overall assets.